Glucocorticoid Dose Reduction and Low Flare Rates in Patients with SLE Receiving Anifrolumab in Routine Practice: 12-Month Interim Analysis of a Multinational Observational Real-World Study (ACR Convergence 2026) - Sep 8, 2026 - Abstract #2206; Pres time: Nov 10, 2026; 10:30 AM - 12:30 PM; Location: WB1&2; In Person; No abstract available
Clinical • Real-world • Real-world evidence • Inflammatory Arthritis
|